Skip to main content

Migraine News

Related terms: Migraine Headache, Hemiplegic Migraine, Complicated Migraine, Basilar-Type Migraine, Basilar Artery Migraine

Stroke Among Younger Adults Linked To Non-Traditional Risks

FRIDAY, April 18, 2025 – Migraines, blood clots in veins, kidney or liver disease, and cancer aren’t typically considered conditions that put a person at increased danger for stroke. But these l...

Study Sheds Light on Role of Risk Factors in Young-Onset Cryptogenic Ischemic Stroke

THURSDAY, April 17, 2025 – Traditional risk factors contribute to young-onset cryptogenic ischemic stroke (CIS) without patent foramen ovale (PFO), while nontraditional risk factors seem more...

Lower Oral Health Scores Linked to Higher Pain Scores in Women

MONDAY, April 14, 2025 – Low oral health scores are associated with higher pain scores, including migraine headache, among women, according to a study published online April 9 in Frontiers in Pain...

ACP Issues Clinical Guideline for Pharmacologic Treatment of Acute Episodic Migraine

FRIDAY, March 21, 2025 – In a clinical guideline issued by the American College of Physicians (ACP) and published online March 18 in the Annals of Internal Medicine, recommendations are presented ...

Combination Therapy Recommended For Migraines

THURSDAY, March 20, 2025 – Doctors should prescribe triptans for migraine patients who aren’t receiving relief from over-the-counter (OTC) pain relievers, according to a new clinical guideline from t...

AAN: Prophylactic Zonisamide Effective in Pediatric Migraine

MONDAY, March 3, 2025 – For pediatric patients with migraine, prophylactic zonisamide use can significantly reduce the median number of headache days per month (HDPM), according to a study scheduled...

ACP Issues Clinical Guideline for Pharmacologic Prevention of Episodic Migraine

MONDAY, Feb. 10, 2025 – In a clinical guideline issued by the American College of Physicians and published online Feb. 4 in the Annals of Internal Medicine, recommendations are presented regarding...

Minority Children Less Likely to Be Diagnosed With Migraine in Emergency Department

WEDNESDAY, Feb. 5, 2025 – Compared with non-Hispanic White (NHW) children, non-Hispanic Black (NHB) and Hispanic/Latino (HL) children with a headache diagnosis in the emergency department have lower...

Too Often, ER Docs Don't Spot Migraines in Minority Kids

THURSDAY, Feb. 6, 2025 – Kids and teens can also get migraines, but Black and Hispanic children seen in ERs are more likely to have their condition go undiagnosed, new research shows. That's...

FDA Approves Symbravo for Acute Treatment of Migraine in Adults

WEDNESDAY, Feb. 5, 2025 – The U.S. Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults. The approval was ...

Beta Blocker Propranolol Might Reduce Migraine Stroke Risk

MONDAY, Feb. 3, 2025 – A common drug used to prevent migraines might have an additional benefit – protecting women against stroke. Women taking the beta blocker propranolol to ward off migraines...

FDA Approves Symbravo (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today an...

Propranolol May Reduce Overall Stroke Risk in Women With Migraine

FRIDAY, Jan. 31, 2025 – Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke, according to a study...

Quick Fix? New Migraine Medicine, Qulipta, May Start Working Right Away

THURSDAY, Dec. 26, 2024 – Migraine patients often suffer a long time before docs zero in on the best dosage for drugs designed to prevent their terrible symptoms. But a recently approved daily...

Atogepant Superior for Efficacy, Functional Measures in Migraine

THURSDAY, Dec. 26, 2024 – For adults with migraine, atogepant 60 mg once daily was superior to placebo for efficacy and functional measures of treatment across three trials, according to research...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Migraine Prevention, Migraine Prophylaxis, Chronic Migraine, Headache

Related drug support groups

gabapentin, ibuprofen, amitriptyline, venlafaxine, propranolol, diclofenac, cyclobenzaprine, topiramate, Botox, view more... sumatriptan, Excedrin, Imitrex, erenumab, Excedrin Migraine, Ubrelvy, verapamil, cyproheptadine, Reglan, Migraine Relief, Nurtec ODT